Abstract:Although systemic mTOR inhibition improves age‐related physiological dysfunction, the cell types that mediate the beneficial effects remain elusive. Here, we demonstrate that endothelial cell‐specific reduction of mTOR ameliorates arterial and metabolic function in old age. These improvements are concomitant with reduced senescence burden, inflammation, and oxidative stress in arteries, lung, adipose tissue, and liver. These results support the exploration of therapeutic strategies targeting endothelial mTOR signaling. Systemic inhibition of the mammalian target of rapamycin (mTOR) delays aging and many age‐related conditions including arterial and metabolic dysfunction. However, the mechanisms and tissues involved in these beneficial effects remain largely unknown. Here, we demonstrate that activation of S6K, a downstream target of mTOR, is increased in arteries with advancing age, and that this occurs preferentially in the endothelium compared with the vascular smooth muscle. Induced endothelial cell‐specific deletion of mTOR reduced protein expression by 60–70%. Although this did not significantly alter arterial and metabolic function in young mice, endothelial mTOR reduction reversed arterial stiffening and improved endothelium‐dependent dilation (EDD) in old mice, indicating an improvement in age‐related arterial dysfunction. Improvement in arterial function in old mice was concomitant with reductions in arterial cellular senescence, inflammation, and oxidative stress. The reduction in endothelial mTOR also improved glucose tolerance in old mice, and this was associated with attenuated hepatic gluconeogenesis and improved lipid tolerance, but was independent of alterations in peripheral insulin sensitivity, pancreatic beta cell function, or fasted plasma lipids in old mice. Lastly, we found that endothelial mTOR reduction suppressed gene expression of senescence and inflammatory markers in endothelial‐rich (i.e., lung) and metabolically active organs (i.e., liver and adipose tissue), which may have contributed to the improvement in metabolic function in old mice. This is the first evidence demonstrating that reducing endothelial mTOR in old age improves arterial and metabolic function. These findings have implications for future drug development.

Canagliflozin shares common mTOR and MAPK signaling mechanisms with other lifespan extension treatments

Cap-independent translation: A shared mechanism for lifespan extension by rapamycin, acarbose, and 17α-estradiol

Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells.

Canagliflozin extends life span in genetically heterogeneous male but not female mice

Sexual identity of enterocytes regulates autophagy to determine intestinal health, lifespan and responses to rapamycin

Neuroprotective effects of Canagliflozin: Lessons from aged genetically diverse UM‐HET3 mice

A combination of the geroprotectors trametinib and rapamycin is more effective than either drug alone

Hypothalamic Sex-Specific Metabolic Shift by Canagliflozin during Aging

Rapalink-1 reveals novel mTOR-dependent genes and an agmatinergic axis-based metabolic feedback regulating mTOR activity and lifespan

Empagliflozin rescues lifespan and liver senescence in naturally aged mice

Rapamycin fed late in life extends lifespan in genetically heterogeneous mice

Targeting the biology of aging with mTOR inhibitors

Germline Signaling Mediates the Synergistically Prolonged Longevity Produced by Double Mutations in Daf-2 and Rsks-1 in C. Elegans

Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice

Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozin

Evolutionary analysis of the mTOR pathway provide insights into lifespan extension across mammals

The mTOR signaling pathway in cardiac aging

Endothelial cell‐specific reduction in mTOR ameliorates age‐related arterial and metabolic dysfunction

Translational Regulation of Non-autonomous Mitochondrial Stress Response Promotes Longevity

Aging--lost in Translation?

Cap-independent mRNA translation is upregulated in long-lived endocrine mutant mice